Comparative effectiveness of infliximab and adalimumab in Crohn’s disease and ulcerative colitis

INTRODUCTION: The availability of monoclonal antibodies to tumor necrosis factor α (anti-TNF) has revolutionized management of Crohn’s disease (CD) and ulcerative colitis (UC). However, limited data exists regarding comparative effectiveness of these agents to inform clinical practice. METHODS: This...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Main Authors: Ananthakrishnan, Ashwin N., Cagan, Andrew, Cai, Tianxi, Gainer, Vivian S., Shaw, Stanley Y, Savova, Guergana, Churchill, Susanne, Karlson, Elizabeth W., Kohane, Isaac, Liao, Katherine P., Murphy, Shawn N.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792716/
https://ncbi.nlm.nih.gov/pubmed/26933751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000754
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares